Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
7.30
-0.47 (-6.05%)
At close: Oct 10, 2025, 4:00 PM EDT
7.46
+0.16 (2.19%)
After-hours: Oct 10, 2025, 5:33 PM EDT

Tenax Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202006 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2006 - 2019
29821652623
Upgrade
Market Cap Growth
2471.77%241.47%21.89%-80.59%11.69%146.95%
Upgrade
Enterprise Value
192.86-73.68-3.093.6520.8117
Upgrade
Last Close Price
7.306.1920.79177.601664.002976.00
Upgrade
PE Ratio
--5.38-0.67-0.30-0.66-1.96
Upgrade
PB Ratio
2.860.230.773.416.185.07
Upgrade
P/TBV Ratio
2.361.030.642.195.044.17
Upgrade
P/FCF Ratio
--1.43-1.05-0.45-2.41-2.53
Upgrade
P/OCF Ratio
--1.43-1.05-0.45-2.41-2.53
Upgrade
EV/EBITDA Ratio
-3.780.38-0.33-0.64-1.74
Upgrade
EV/EBIT Ratio
-3.780.38-0.33-0.64-1.72
Upgrade
EV/FCF Ratio
-4.970.52-0.32-1.92-1.83
Upgrade
Debt / Equity Ratio
000.060.460.040.05
Upgrade
Debt / EBITDA Ratio
---0.06-0.06-0.01-0.02
Upgrade
Debt / FCF Ratio
---0.08-0.06-0.02-0.03
Upgrade
Quick Ratio
41.7320.212.731.153.573.17
Upgrade
Current Ratio
41.8920.603.261.743.643.21
Upgrade
Return on Equity (ROE)
-31.73%-35.08%-159.80%-385.76%-743.70%-235.48%
Upgrade
Return on Assets (ROA)
-34.60%-35.98%-109.13%-235.24%-508.96%-149.13%
Upgrade
Return on Capital (ROIC)
--7766.53%-1245.17%-1967.05%-13172.68%-5219.50%
Upgrade
Return on Capital Employed (ROCE)
-35.88%-38.95%-170.57%-369.33%-713.19%-229.95%
Upgrade
Earnings Yield
-10.55%-18.58%-149.30%-338.24%-151.73%-51.08%
Upgrade
FCF Yield
-6.65%-69.94%-95.21%-223.84%-41.43%-39.52%
Upgrade
Buyback Yield / Dilution
-2.62%-474.00%-228.87%-155.88%-37.14%-44.11%
Upgrade
Total Shareholder Return
--474.00%-228.87%-155.88%-37.14%-44.11%
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q